Federal Drug Policy Discussions Signal Potential Shift in Cannabis Classification
The United States appears to be approaching a major turning point in federal drug policy, especially regarding cannabis. After more than fifty years with an unchanged classification system, growing bipartisan support and shifting public attitudes suggest that reform may be close. Cannabis is currently listed as a Schedule I substance, a category reserved for drugs […] More









